Since autoreactive T cells selectively recognize antigenic epitopes specific for pancreatic β cells, part of the research in T1D sails in uncharted waters to discover neoantigens, epitopes and their presentation mechanisms, which can explain why CD4+ and CD8+ T cells build an autoreactive immune response in T1D. This evidence concerns the gene CD4 and type 1 diabetes mellitus.